tolterodinetartraat sandoz 2 mg, filmomhulde tabletten
sandoz b.v. veluwezoom 22 1327 ah almere - tolterodinetartraat 2 mg/stuk samenstelling overeenkomend met ; tolterodine 1,68 mg/stuk - filmomhulde tablet - calciumwaterstoffosfaat 0-water (e 341) ; cellulose, microkristallijn (e 460(i)) ; hypromellose (e 464) ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat ; siliciumdioxide (e 551) ; stearinezuur (e 570) ; titaandioxide (e 171), calciumwaterstoffosfaat 0-water (e 341) ; cellulose, microkristallijn (e 460) ; hypromellose (e 464) ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat ; siliciumdioxide (e 551) ; stearinezuur (e 570) ; titaandioxide (e 171), calciumwaterstoffosfaat 0-water (e 341) ; cellulose, microkristallijn (e 460) ; hypromellose (e 464) ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat (e468) ; siliciumdioxide (e 551) ; stearinezuur (e 570) ; titaandioxide (e 171), - tolterodine
hepcludex
gilead sciences ireland uc - bulevirtide acetate - hepatitis d, chronic - antivirale middelen voor systemisch gebruik - hepcludex is indicated for the treatment of chronic hepatitis delta virus (hdv) infection in plasma (or serum) hdv-rna positive adult patients with compensated liver disease.
copiktra
secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - antineoplastische middelen - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies. follicular lymphoma (fl) that is refractory to at least two prior systemic therapies.
retsevmo
eli lilly nederland b.v. - selpercatinib - carcinoma, non-small-cell lung; thyroid neoplasms - antineoplastische middelen - retsevmo as monotherapy is indicated for the treatment of adults and adolescents 12 years and older with advanced ret-mutant medullary thyroid cancer (mtc)advanced ret fusion-positive non-small cell lung cancer (nsclc) not previously treated with a ret inhibitoradvanced ret fusion-positive thyroid cancer who require systematic therapy following prior treatment.